Iovance Biotherapeutics, Inc. (IOVA) Insider Trading

Over the last 6 months, 121 institutions increased and 64 reduced their position (13F).

Insider Activity

Sentiment
50/100
Buys (3m)
0
Sells (3m)
0
Net (3m)
$0
Insider trades by month Buys Sells
Nov
May
Jun
Context3-month price +99.9%Institutions reducing (13F)
DateInsiderTypeSharesPrice
Aug 12, 2026Kirby Daniel Gordonofficer: Chief Commercial OfficerOption10,001
Aug 12, 2026Kirby Daniel Gordonofficer: Chief Commercial OfficerTax2,436$6.40
Aug 10, 2026Roche Corleen M.officer: Chief Financial OfficerOption49,995
Aug 10, 2026Roche Corleen M.officer: Chief Financial OfficerTax21,238$6.21
Jun 18, 2026WEISER MICHAELdirectorGrant90,316
Jun 18, 2026Countouriotis AthenadirectorGrant90,316
Jun 18, 2026Dukes Iain D.directorGrant180,632
Jun 18, 2026Puri Raj K.officer: Chief Regulatory OfficerGrant15,000
Jun 18, 2026Maynard Ryan DdirectorGrant90,316
Jun 9, 2026Puri Raj K.officer: Chief Regulatory OfficerOption9,766
Jun 9, 2026BILINSKY IGORofficer: Chief Operating OfficerTax3,976$4.23
Jun 9, 2026GRAF FINCKENSTEIN FRIEDRICHofficer: Chief Medical OfficerOption7,813
Jun 9, 2026Puri Raj K.officer: Chief Regulatory OfficerTax3,843$4.23
Jun 9, 2026Vogt Frederick Gdirector, officer: Interim CEO & General CounselOption15,625
Jun 9, 2026GRAF FINCKENSTEIN FRIEDRICHofficer: Chief Medical OfficerTax3,976$4.23
Jun 9, 2026Vogt Frederick Gdirector, officer: Interim CEO & General CounselTax6,638$4.23
Jun 9, 2026BILINSKY IGORofficer: Chief Operating OfficerOption7,813
Jun 3, 2026Vogt Frederick Gdirector, officer: Interim CEO & General CounselOption41,668
Jun 3, 2026Puri Raj K.officer: Chief Regulatory OfficerOption5,469
Jun 3, 2026BILINSKY IGORofficer: Chief Operating OfficerTax4,473$3.96
Jun 3, 2026BILINSKY IGORofficer: Chief Operating OfficerOption8,790
Jun 3, 2026Puri Raj K.officer: Chief Regulatory OfficerTax2,508$3.96
Jun 3, 2026GRAF FINCKENSTEIN FRIEDRICHofficer: Chief Medical OfficerTax4,473$3.96
Jun 3, 2026Vogt Frederick Gdirector, officer: Interim CEO & General CounselTax17,701$3.96
Jun 3, 2026GRAF FINCKENSTEIN FRIEDRICHofficer: Chief Medical OfficerOption8,790
May 13, 2026Kirby Daniel Gordonofficer: Chief Commercial OfficerOption10,000
May 13, 2026Kirby Daniel Gordonofficer: Chief Commercial OfficerTax2,435$3.70
Mar 11, 2026BILINSKY IGORofficer: Chief Operating OfficerGrant117,500
Mar 11, 2026Kirby Daniel Gordonofficer: Chief Commercial OfficerGrant132,200
Mar 11, 2026GRAF FINCKENSTEIN FRIEDRICHofficer: Chief Medical OfficerGrant58,750

Source: IOVA SEC Form 4 filings, latest Aug 12, 2026. For informational purposes only — not investment advice.

Institutional activity (13F)

How institutions changed their IOVA positions over the last 6 months (SEC Form 13F).

Increased
121
New positions
67
Reduced
64
Sold out
286
Largest moves
InstitutionActionSharesFiled
BLACKROCK, INC.Increased31.1MMay 13, 2026
MHR FUND MANAGEMENT LLCUnchanged29.0MMay 15, 2026
STATE STREET CORPReduced17.4MMay 15, 2026
VANGUARD CAPITAL MANAGEMENT LLCNew Position16.6MMay 15, 2026
TWO SIGMA INVESTMENTS, LPIncreased13.7MMay 15, 2026
VANGUARD PORTFOLIO MANAGEMENT LLCNew Position11.7MMay 8, 2026
MILLENNIUM MANAGEMENT LLCIncreased9.4MMay 15, 2026
GOLDMAN SACHS GROUP INCReduced8.8MMay 15, 2026
GOLDMAN SACHS GROUP INCIncreased8.6MMar 25, 2026
GEODE CAPITAL MANAGEMENT, LLCIncreased8.6MMay 15, 2026
INVENOMIC CAPITAL MANAGEMENT LPReduced8.5MMay 15, 2026
BANK OF AMERICA CORP /DE/Reduced8.5MMay 18, 2026
D. E. SHAW & CO., INC.Increased8.0MMay 15, 2026
SUSQUEHANNA INTERNATIONAL GROUP, LLPReduced6.7MMay 15, 2026
PALO ALTO INVESTORS LPReduced6.3MMay 15, 2026

Source: SEC Form 13F filings. For informational purposes only — not investment advice.